FRA:FRE

Fresenius SE & Co. KGaA (FRE) Stock Forecast, Price & News

€25.59

-0.57 (-2.18%)

(As of 05/31/2023 ET)

Compare

Today's Range: €25.58
▼
€26.13
50-Day Range: €23.60
▼
€28.22
52-Week Range: €60.16
▼
€80.00

Volume: 2.00 million shs
Average Volume: N/A
Market Capitalization: N/A

P/E Ratio: N/A
Dividend Yield: N/A
Price Target: €31.54

Profile Analyst Ratings Chart Competitors Insider Trades Headlines

About Fresenius SE & Co. KGaA (FRA:FRE) Stock

Fresenius SE & Co. KGaA, a health care company, provides products and services for dialysis, hospitals, and outpatient medical care. It operates through four segments: Fresenius Medical Care, Fresenius Kabi, Fresenius Helios, and Fresenius Vamed. The Fresenius Medical Care segment offers products and services for patients with chronic kidney failure. This segment provides dialyzers, hemodialysis machines, and related disposable products, as well as dialysis-related services. The Fresenius Kabi segment engages in the therapy and care of therapy and care ill patients. This segment offers IV drugs, including intravenously administered generic drugs for oncology, anesthetics, analgesics, anti-infectives, and critical care; parenteral and enteral nutrition products; infusion solutions and blood volume substitutes for infusion therapy; biosimilars, a biological medicine for autoimmune and oncology diseases; medical devices and disposal used to administer IV generic drugs, infusion therapies, and clinical nutrition products; and transfusion products for collection of blood components and corporeal therapies. The Fresenius Helios segment operates 90 hospitals, approximately 130 outpatient clinics, and 6 prevention centers in Germany; and 49 hospitals, 88 outpatient clinics, and approximately 300 risk prevention centers in Spain. This segment also provides services in the field of fertility treatments through 33 clinics and additional 39 sites across 10 countries on 3 continents. The Fresenius Vamed segment manages projects and offers services for hospitals and other health care facilities. This segment provides project development, planning, and turnkey construction services, as well as maintenance, technical management, and operational management services. The company was formerly known as Fresenius SE and changed its name to Fresenius SE & Co. KGaA in January 2011. Fresenius SE & Co. KGaA was founded in 1912 and is headquartered in Bad Homburg vor der Höhe, Germany.

Receive FRE Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Fresenius SE & Co. KGaA and its competitors with MarketBeat's FREE daily newsletter.

FRE Stock News Headlines

May 25, 2023 | finance.yahoo.com

Fresenius shares rise; Kabi raises 2023 outlook

May 15, 2023 | marketwatch.com

Unfractionated Heparin Market: Recent Growing Trend 2030

June 1, 2023 | Edge On The Street (Ad)

The $193 Billion US-China War You Don't Know About

They're fighting for control of lithium – a key ingredient in EVs and clean energy technology. It's arguably the most important commodity of the 21st century. China owns 80% of global supply. But the US plans to grab a massive slice of the lithium market, which is forecasted to quadruple to $193 billion by 2028, according to Fortune Business Insights.

May 9, 2023 | markets.businessinsider.com

Fresenius SE & Co. Q1 Profit Declines, Revenue Up 5%; Confirms FY23 Guidance

May 4, 2023 | finance.yahoo.com

Fresenius Medical Care AG & Co. KGaA (ETR:FME) is a favorite amongst institutional investors who own 44%

April 27, 2023 | seekingalpha.com

FSNUF Fresenius SE & Co. KGaA

April 21, 2023 | msn.com

Germany stocks mixed at close of trade; DAX up 0.54%

April 19, 2023 | seekingalpha.com

FSNUY Fresenius SE & Co. KGaA

June 1, 2023 | Edge On The Street (Ad)

Graphite versus Lithium - What Investors Should Know

Over 18 million EVs will be cruising U.S roads by 2030. And every one million EVs manufactured will require 82,000 tons of the metal graphite for their batteries. That's a total of 1,476,000 tons of graphite! Graphite is actually the largest component of EV batteries - NOT lithium. Experts warn of a massive graphite shortfall, especially since North America currently has no operating graphite mines.

April 14, 2023 | marketwatch.com

Fluid Management Market | Share, Trends, Growth Till 2031

April 13, 2023 | finance.yahoo.com

Investors Could Be Concerned With Fresenius SE KGaA's (ETR:FRE) Returns On Capital

April 6, 2023 | finance.yahoo.com

Global Empty IV Bags Market Report 2023: Prohibition of the use of IV Bags Made of PVC Boosts the Rate of Growth

April 6, 2023 | marketwatch.com

Pain Management Market 2023 Size and Forecast to 2031

March 31, 2023 | msn.com

Germany stocks higher at close of trade; DAX up 0.69%

March 30, 2023 | marketwatch.com

IV Bags Market 2023 Size and Forecast to 2031

March 24, 2023 | americanbankingnews.com

Berenberg Bank Analysts Give Fresenius SE & Co. KGaA (FRA:FRE) a €44.50 Price Target

March 14, 2023 | marketwatch.com

Gonadotropins Market | 75 Pages by 360 Market Updates

March 7, 2023 | finance.yahoo.com

Q4 2022 Cara Therapeutics Inc Earnings Call

February 24, 2023 | seekingalpha.com

Fresenius SE & Co. KGaA (FSNUF) Q4 2022 Earnings Call Transcript

February 22, 2023 | finance.yahoo.com

Fresenius sinks, FMC rises after CEO signals strategy change

February 20, 2023 | marketwatch.com

Patient-controlled Analgesic Pump Market Examining Industry Trends in 2023 and Beyond: Forecasting Advancement Outlook until 2028

February 14, 2023 | marketwatch.com

Blood Bags Market with Foretelling Strategy Throughout 2023-2028

February 8, 2023 | finance.yahoo.com

Are Investors Undervaluing Fresenius SE & Co. KGaA (ETR:FRE) By 36%?

February 2, 2023 | marketwatch.com

Blood Purification Equipment Market Size and Market Drivers Analysis 2023 | Competitive Landscape, Regional Status, Prospect and Forecast to 2028

February 2, 2023 | markets.businessinsider.com

EQS-News: Formycon and Fresenius Kabi conclude global commercialization partnership for FYB202, a biosimilar candidate to Stelara®1 (ustekinumab)

January 23, 2023 | marketwatch.com

Hemodialysis Equipment Market 2023 : Recent Developments, Industry Trends and Investigation Growth Rate, and Forecast to 2028

January 11, 2023 | marketwatch.com

Portable Hemodialysis Machine Market Experiences Significant Growth Over the 2023-2029 Timeframe, Credited to Technological Advances

See More Headlines

FRE Price History

30 days | 90 days | 365 days | Advanced Chart

Industry, Sector and Symbol

Stock Exchange: FRA
Industry: Medical Care Facilities
Sub-Industry: N/A
Sector: Medical
Current Symbol: FRA:FRE
CUSIP: N/A
CIK: N/A
Web: www.fresenius.de
Phone: +49-6172-6080
Fax: N/A
Employees: 316,078
Year Founded: N/A

Price Target and Rating

Average Stock Price Forecast: €31.54
High Stock Price Forecast: €44.50
Low Stock Price Forecast: €22.00
Forecasted Upside/Downside: +23.3%
Consensus Rating: N/A
Rating Score (0-4): 0.00
Research Coverage: 0 Analysts

Profitability

EPS (Most Recent Fiscal Year): N/A
Trailing P/E Ratio: N/A
Forward P/E Ratio: N/A
P/E Growth: N/A
Net Income: N/A
Net Margins: N/A
Pretax Margin: N/A
Return on Equity: N/A
Return on Assets: N/A

Debt

Debt-to-Equity Ratio: N/A
Current Ratio: N/A
Quick Ratio: N/A

Sales & Book Value

Annual Sales: N/A
Price / Sales: N/A
Cash Flow: N/A
Price / Cash Flow: N/A
Book Value: N/A
Price / Book: N/A

Miscellaneous

Outstanding Shares: N/A
Free Float: N/A
Market Cap: N/A
Optionable: Not Optionable
Beta: N/A

Key Executives

Mr. Michael Sen (Age 54)
CEO, Pres & Chairman of Management Board - Fresenius Management SE
Comp: $2.23M

Dr. Francesco De Meo (Age 59)
Member of Management Board - Fresenius Management SE
Comp: $2.35M

Dr. Ernst Wastler (Age 64)
Member of Management Board - Fresenius Management SE
Comp: $1.8M

Dr. Sebastian Biedenkopf (Age 58)
Chief Legal Officer, HR, Labor Relations Director, Risk Mgmt & Member of Mgmt. Board
Comp: $1.51M

Ms. Sara Hennicken (Age 42)
CFO & Member of the Management Board - Fresenius Management SE

Ms. Helen Giza (Age 54)
Member of the Management Board - Fresenius Management SE

Mr. Markus Georgi
Sr. VP of Investor Relations

Matthias Link
Sr. VP Corp. Communications

Key Competitors

View All Competitors

FRE Stock - Frequently Asked Questions

What is Fresenius SE & Co. KGaA's stock price forecast for 2023?: 0 analysts have issued 1-year price targets for Fresenius SE & Co. KGaA's shares. Their FRE share price forecasts range from €22.00 to €44.50. On average, they anticipate the company's share price to reach €31.54 in the next twelve months. This suggests a possible upside of 23.3% from the stock's current price.
View analysts price targets for FRE or view top-rated stocks among Wall Street analysts.
How have FRE shares performed in 2023?: Fresenius SE & Co. KGaA's stock was trading at €26.25 on January 1st, 2023. Since then, FRE shares have decreased by 2.5% and is now trading at €25.59.
View the best growth stocks for 2023 here.
What other stocks do shareholders of Fresenius SE & Co. KGaA own?: Based on aggregate information from My MarketBeat watchlists, some companies that other Fresenius SE & Co. KGaA investors own include Illumina (ILMN), Daimler (DAI), Endologix (ELGX), Allianz (ALV), Cambrex (CBM), Linde (LIN), Alibaba Group (BABA), General Electric (GE) and HeidelbergCement (HEI).

What is Fresenius SE & Co. KGaA's stock symbol?: Fresenius SE & Co. KGaA trades on the FRA under the ticker symbol "FRE."
What is Fresenius SE & Co. KGaA's stock price today?: One share of FRE stock can currently be purchased for approximately €25.59.
How many employees does Fresenius SE & Co. KGaA have?: The company employs 316,078 workers across the globe.
How can I contact Fresenius SE & Co. KGaA?: Fresenius SE & Co. KGaA's mailing address is Else-Kroener-Str. 1, BAD HOMBURG VOR DER HOEHE, 61352, Germany. The official website for the company is www.fresenius.de. The company can be reached via phone at +49-6172-6080.

This page (FRA:FRE) was last updated on 6/1/2023 by MarketBeat.com Staff

Get 30 Days of MarketBeat All Access Free

Best-in-Class Portfolio Monitoring
View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio.
Stock Ideas and Recommendations
Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report.
Advanced Stock Screeners and Research Tools
Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis.

Start Your 30-Day Free Trial